Glucagon-like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time?. Canadian Diabetes & Endocrinology Today, [S. l.], v. 4, n. 1, p. 5–9, 2026. DOI: 10.58931/cdet.2026.4149. Disponível em: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/4-1-Goldenberg. Acesso em: 26 may. 2026.